CN109503704A - A kind of recombinant human iron separation and purification of protein method - Google Patents

A kind of recombinant human iron separation and purification of protein method Download PDF

Info

Publication number
CN109503704A
CN109503704A CN201811622011.8A CN201811622011A CN109503704A CN 109503704 A CN109503704 A CN 109503704A CN 201811622011 A CN201811622011 A CN 201811622011A CN 109503704 A CN109503704 A CN 109503704A
Authority
CN
China
Prior art keywords
buffer
chromatographic column
elution buffer
bestarose
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811622011.8A
Other languages
Chinese (zh)
Inventor
崔晴晴
张洪
时鑫
倪春杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pinghu Youpu Biotechnology Co Ltd
Original Assignee
Pinghu Youpu Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pinghu Youpu Biotechnology Co Ltd filed Critical Pinghu Youpu Biotechnology Co Ltd
Priority to CN201811622011.8A priority Critical patent/CN109503704A/en
Publication of CN109503704A publication Critical patent/CN109503704A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a kind of recombinant human iron separation and purification of protein methods, comprising the following steps: obtains bacterium mud after the centrifugation of Escherichia coli bacteria liquid after fermentation, bacterium mud heated after being dissolved in buffer, is centrifuged or filtration treatment, and filtrate is obtained;The filtrate that step 1) obtains is separated using anion chromatography, collects the elution buffer containing destination protein;The elution buffer containing destination protein is obtained to step 2) using cation chromatography and carries out secondary separation, collects the elution buffer containing destination protein;It is separated three times using elution buffer of the hydrophobic chromatography to the ferritin containing purpose that step 3) obtains, collects the elution buffer containing destination protein.The present invention has the advantages that easy to operate, destination protein rate of recovery height, with high purity.

Description

A kind of recombinant human iron separation and purification of protein method
[technical field]
The present invention relates to the technical field of protein separation, especially a kind of recombinant human iron separation and purification of protein method Technical field.
[background technique]
Ferritin (Ferritin) is widely present in various organisms, is formed by 24 subunits are spontaneous, and caged albumen is multiple Whole body structure is a kind of natural polymeric biomaterial.It has the function of storage ferro element, anti-oxidant etc. in vivo, But as a kind of natural high molecular material, it also can be used as nano-carrier and be widely used in drug conveying, medical imaging etc., while iron Albumen can be used for the Clinics and Practices of tumour in conjunction with the TfR of high efficient expression in tumour cell.Ferritin can High efficient expression is obtained in Escherichia coli with transgenic technology, then carries out isolating and purifying for the broken realization albumen of somatic cells. Traditional ferritin isolation and purification method mostly uses greatly the precipitation method, including ethanol precipitation, rivanol precipitating and ammonium sulfate precipitation, but It is all lower using ferritin relative purity and the rate of recovery made from the precipitation method, after gradually adopt chromatography replace the precipitation method, pass through The chromatography schemes such as ion-exchange chromatography and hydrophobic chromatography isolate and purify ferritin.But existing some chromatography exist back Yield is low, and every step chromatography requires to carry out that desalination dilution operation is relatively complicated to be unfavorable for being mass produced, and the purity of ferritin is also The rank of medical supplies cannot be reached.
[summary of the invention]
The object of the invention is to solve the problems of the prior art, a kind of recombinant human iron separation and purification of protein side is proposed Method can make ferritin isolation and purification method is easy to operate to be suitble to be mass produced, and protein recovery is high, purity is high.
To achieve the above object, the invention proposes a kind of recombinant human iron separation and purification of protein methods, comprising the following steps:
1) bacterium mud is obtained after the Escherichia coli bacteria liquid centrifugation after fermenting, bacterium mud is heated after being dissolved in buffer, is centrifuged Or filtration treatment, obtain filtrate;
2) filtrate that step 1) obtains is separated using anion chromatography, collects the elution buffer of ferritin;
3) secondary separation is carried out using the elution buffer that cation chromatography obtains ferritin to step 2), collects iron content The elution buffer of albumen;
4) it is separated three times using elution buffer of the hydrophobic chromatography to the ferritin that step 3) obtains, collects iron content The elution buffer of albumen.
Preferably, the buffer of dissolution bacterium mud is 5-100mM PB or Tris pH7.0, the step in the step 1) Rapid 1) the middle temperature range heated and time are respectively 70-75 DEG C, 5-15min, and filtration treatment uses in the step 1) 0.22um doughnut or membrane filtration processing mode.
Preferably, the step 2) specifically: take the chromatographic column equipped with anion chromatography medium, handled with 0.5MNaOH Chromatographic column balances loading after chromatographic column with combination buffer later, then with cleaning buffer solution cleans impurity, with elution buffer into Row elution, collects the elution buffer of ferritin, cleans the stronger impurity of binding ability with 0.5M NaOH, use 10mM NaOH saves chromatographic column.
Preferably, anion chromatography medium is Q Bestarose High Performance, Q in the step 2) Sepharose High Performance、DEAE Bestarose High Performance、DEAE Sepharose High Performance、SOURCE Q、Q Bestarose Fast Flow、Q Sepharose Fast Flow、DEAE Bestarose Fast Flow、DEAE Sepharose Fast Flow、Q Bestarose Big Beads、Q sepharose Big Beads、Q Bestarose Big Beads、Q sepharose Big Beads、Diamond Q、 Capto Q, Diamond Q mustang, Capto Q mustang, Capto DEAE, Diamond DEAE or Diamond One of DEAE mustang;Combination buffer is 5-100mM PB or Tris pH7.0 in the step 2);The step 2) cleaning buffer solution is one in 5-100mM PB or MES pH6.0 or 5-100mM PB or Tris 0.1M NaCl pH7.0 in Kind;Elution buffer is 5-100mM NaAC pH4.5 or 5-100mMPB 0.25MNaCl pH7.0 in the step 2);It is described The PH and conductance that combination buffer balances chromatographic column to efflux in step 2) keep one with the PH of combination buffer and conductance It causes.
Preferably, the step 3) is specially;The chromatographic column equipped with cationic chromatography media is taken, is handled with 0.5MNaOH Chromatographic column balances loading after chromatographic column with combination buffer later, then is eluted with elution buffer, collects ferritin Elution buffer cleans the stronger impurity of binding ability with 0.5M NaOH, saves chromatographic column with 10mM NaOH.
Preferably, step 3) the middle-jiao yang, function of the spleen and stomach ion chromatography medium is SP Bestarose High Performance, SP Sepharose High Performance、Diamond MMC、Capto MMC、Diamond MMC mustang、Capto MMC impres、SP Bestarose Fast Flow、SP Sepharose Fast Flow、Capto SP impres、 One of Diamond SP mustang, CM Bestarose Fast Flow or CM Sepharose Fast Flow;Institute Stating combination buffer in step 3) is 5-100mM NaAc pH5.0 or 5-100mM NaAc 0.2M NaCl pH5.0;The step It is rapid 3) in elution buffer be 5-100mM PB 0.01M NaCl pH6.0 or 5-100mM PB pH6.0;In the step 3) The PH and conductance of combination buffer balance chromatographic column to efflux are consistent with the PH of combination buffer and conductance.
Preferably, the step 4) is specially;The chromatographic column equipped with hydrophobic chromatoghaphy medium is taken, is handled with 0.5M NaOH Chromatographic column balances loading after chromatographic column with combination buffer later, then is eluted with elution buffer, collects ferritin Elution buffer, elutes impurity with pure water, cleans chromatographic column with 0.5M NaOH, saves chromatographic column with 10mM NaOH.
Preferably, in the step 4) hydrophobic chromatoghaphy medium be Butyl Bestarose High Performance, Butyl Sepharose High Performance、Diamond Butyl mustang、Capto Butyl impres、 Butyl Bestarose Fast Flow、Phenyl Sepharose Fast Flow HS、Phenyl Sepharose Fast Flow LS、Phenyl Bestarose Fast Flow HS、Phenyl Bestarose Fast Flow LS、Butyl Sepharose Fast Flow、Diamond butyl、Capto butyl、Capto Phenyl HS、Capto Phenyl One of impres, Diamond Phenyl mustang or Diamond Phenyl;Combination buffer in the step 4) For 5-100mM PB or Tris0.8-2M Na2SO4pH7.0,5-100mM PB or Tris 1.5-3M NaCl pH7.0,5- 100mM PB or Tris 0.8-2.5M (NH4)2SO4PH7.0 or 5-100mM PB or Tris 0.8-2M K2In HPO4pH7.0 It is a kind of;Elution buffer is 5-100mM PB or Tris 0.2-0.5M Na2SO4pH7.0,5-100mM PB in the step 4) Or Tris 0.8-1.2M NaCl pH7.0,5-100mM PB or Tris 0.4-0.8M (NH4)2SO4pH7.0、5-100mM PB Or Tris 0.4-0.8M K2One of HPO4pH7.0;Combination buffer balances chromatographic column to efflux in the step 4) PH and conductance be consistent with the PH of combination buffer and conductance.
Preferably, the step 1), step 2), step 3) and step 4) are both needed to carry out albumen Indexs measure.
Preferably, the albumen index Indexs measure uses gel filtration detection and ion chromatography detection mode.
Beneficial effects of the present invention: the present invention is using anion chromatography, cation chromatography and three step chromatography side of hydrophobic chromatography Ferritin purity made from formula and the rate of recovery are high, purity >=97%, can reach medical supplies rank, do not needed between every step chromatography into The cumbersome desalination dilution operation of row, method is easy to operate, is suitble to large-scale production, by using gel filtration detection and ion color Spectrum detection detects every step chromatographic elution sample, increases the reliability of ferritin isolation and purification method.
Feature and advantage of the invention will be described in detail by embodiment combination attached drawing.
[Detailed description of the invention]
Fig. 1 is a kind of gel mistake of the step 1) process of the embodiment 1 of recombinant human iron separation and purification of protein method of the present invention Filter detection figure;
Fig. 2 is at a kind of step 2) anion chromatography of the embodiment 1 of recombinant human iron separation and purification of protein method of the present invention Reason process gel filtration detection figure;
Fig. 3 is at a kind of cationic chromatography of step 3) of the embodiment 1 of recombinant human iron separation and purification of protein method of the present invention Reason process gel filtration detection figure;
Fig. 4 is a kind of step 4) the hydrophobic chromatography processing of embodiment 1 of recombinant human iron separation and purification of protein method of the present invention Process gel filtration detection figure;
Fig. 5 is a kind of step 1) process gel filtration of the embodiment 2 of recombinant human iron separation and purification of protein method of the present invention Detection figure;
Fig. 6 is at a kind of step 2) anion chromatography of the embodiment 2 of recombinant human iron separation and purification of protein method of the present invention Reason process gel filtration detection figure;
Fig. 7 is at a kind of cationic chromatography of step 3) of the embodiment 2 of recombinant human iron separation and purification of protein method of the present invention Reason process gel filtration detection figure;
Fig. 8 is a kind of step 4) the hydrophobic chromatography processing of embodiment 2 of recombinant human iron separation and purification of protein method of the present invention Process gel filtration detection figure;
Fig. 9 is the ion of filtrate sample before a kind of three step Image processings of recombinant human iron separation and purification of protein method of the present invention Detection figure;
Figure 10 is the ion inspection of sample after a kind of three step Image processings of recombinant human iron separation and purification of protein method of the present invention Mapping;
Figure 11 is a kind of blank ion detection comparative diagram of recombinant human iron separation and purification of protein method of the present invention.
[specific embodiment]
Embodiment 1, a kind of recombinant human iron separation and purification of protein method of the present invention, comprising the following steps:
1) bacterium mud will be obtained after the centrifugation of 10g escherichia coli fermented broth, bacterium mud is that 20mM PB is added in 1:10 by mass volume ratio PH7.0, after stirring evenly, high-pressure homogenization is twice broken under 800bar environment, is heated to 72 DEG C and constant heating 5min, 12000g are centrifuged Lower centrifugal treating 10min is acted on, supernatant is removed later, with 0.22um membrane filtration, obtains filtrate, gel filtration inspection is carried out to filtrate It surveys and ion chromatography detects;
2) anion chromatography is handled: being taken 30ml anion chromatography MEDIUM Q Bestarose High Performance, is filled Into BXK16/20 chromatographic column, following chromatography process is carried out on AKTA protein purification instrument, handles anion with 0.5M NaOH Chromatography media, then maintained an equal level position with 120ml combination buffer 50mM PBpH7.0 balance chromatographic column to baseline, take 100ml's The filtrate tune PH to 7.0 obtained by step 1), loading clean impurity with 100ml cleaning buffer solution 25mM PB pH6.0, use 100ml elution buffer 50mM PB 0.25M NaCl pH7.0 elution purpose ferritin and the elution buffer for collecting ferritin Liquid cleans impurity with 40ml 25mM PB 1M NaCl pH7.0, cleans pillar with 40ml 0.5M NaOH later, wash away and do not wash De- combination foreign protein is balanced with 10mM NaOH and saves chromatographic column, carries out gel filtration inspection to the elution buffer of ferritin It surveys and ion chromatography detects, it is 97% which, which obtains destination protein purity in the elution buffer of ferritin, The rate of recovery is 76.8%, carrying capacity 30mg/ml;
3) cationic Image processing: appropriate cation chromatography media SP Bestarose High Performance dress is taken Enter BXK16/20, column bed height is 11.3cm, chromatographic column is handled with 40ml 0.5M NaOH, with combination buffer 50mM NaAc PH5.0 balances chromatographic column, takes the elution buffer sample 145ml of the ferritin obtained by step 2), adjusts pH to 5.0, loading, It is cleaned with combination buffer, elutes destination protein with 60ml elution buffer 20mM PB 0.01MNaCl pH6.0, it is pure with 3CV Pillar is cleaned with 3CV NaOH after water elution impurity, 10mM NaOH saves chromatographic column, carries out to the elution buffer of ferritin Gel filtration detection and ion chromatography detection, it is pure which chromatographs to obtain destination protein in the elution buffer of ferritin Degree is 97.7%, the rate of recovery 99.3%, carrying capacity 10mg/ml;
4) hydrophobic chromatography is handled: appropriate hydrophobic chromatoghaphy medium Butyl Bestarose High Performance being taken to be packed into BXK16/20, column bed height are 11cm, chromatographic column are handled with 40ml 0.5M NaOH, with combination buffer 20mM PB 1.0M Na2SO4pH7.0 balances chromatographic column, takes the elution buffer sample 10ml of the ferritin obtained by step 3), sample adds Na2SO4 tune conductance is extremely identical as the conductance of combination buffer, adjusts pH7.0, and loading is cleaned with combination buffer, uses elution buffer Liquid 20mM PB 0.5M Na2SO4pH7.0 elutes destination protein, cleans column with 60ml NaOH after eluting impurity with 60ml pure water Son, 10mM NaOH save chromatographic column, carry out gel filtration detection to the elution buffer of ferritin and ion chromatography detects, It is 98.7% that the step hydrophobic chromatography, which obtains destination protein purity in the elution buffer of ferritin, and the rate of recovery 68.2% carries Amount is 20mg/ml;
It is 27.89min that step 1) can get filtrate sample gel filtration testing goal albumen appearance time refering to fig. 1;
Step 2) can get washing using anion chromatography MEDIUM Q Bestarose High Performance refering to Fig. 2 De- buffer sample gel filtration testing goal albumen appearance time is 27.92min;
Step 3) can get refering to Fig. 3 using cation chromatography media SP Bestarose High Performance's Elution buffer sample gel filtration testing goal albumen appearance time is 27.85min;
Step 4) can get refering to Fig. 4 using hydrophobic chromatoghaphy medium Butyl Bestarose High Performance's Elution buffer sample gel filtration testing goal albumen appearance time is 27.96min.
Embodiment 2, a kind of recombinant human iron separation and purification of protein method of the present invention, comprising the following steps:
1) bacterium mud will be obtained after the centrifugation of 10g escherichia coli fermented broth, bacterium mud is that 20mM PB is added in 1:10 by mass volume ratio PH7.0, after stirring evenly, high-pressure homogenization is twice broken under 800bar environment, is heated to 72 DEG C and constant heating 5min, 12000g are centrifuged Lower centrifugal treating 10min is acted on, supernatant is removed later, with 0.22um membrane filtration, obtains filtrate, gel filtration inspection is carried out to filtrate It surveys and ion chromatography detects;
2) anion chromatography is handled: 40ml anion chromatography medium DEAE Bestarose High Performance is taken, Be attached in BXK16/20 chromatographic column, following chromatography process carries out on AKTA protein purification instrument, with 0.5M NaOH handle yin from Sub- chromatography media, then maintained an equal level position with 120ml combination buffer 50mM PB pH7.0 balance chromatographic column to baseline, take 100ml The filtrate tune PH to 7.0 obtained by step 1), loading is clear with 100ml cleaning buffer solution 50mM PB 0.1M NaCl pH7.0 Impurity is washed, elute purpose ferritin with 120ml elution buffer 50mM PB 0.25M NaCl pH7.0 and collects ferritin Elution buffer, clean impurity with the 50mM PB 1M NaCl pH7.0 of 40ml, clean column with 40ml 0.5MNaOH later Son washes away the binding protein not eluted, is balanced with 10mM NaOH and saves chromatographic column, carries out to the elution buffer of ferritin Gel filtration detection and ion chromatography detection, it is pure which obtains destination protein in the elution buffer of ferritin Degree is 76.48%, the rate of recovery 80%, carrying capacity 30mg/ml;
3) cationic Image processing: taking appropriate cation chromatography media Diamond MMC mustang to be packed into BXK16/20, Column bed height is 13cm, chromatographic column is handled with 40ml 0.5M NaOH, with combination buffer 20mMNaAc 0.2M NaCl PH5.0 balances chromatographic column, takes the elution buffer sample 145ml of the ferritin obtained by step 2), sample is diluted with pure water It is extremely identical with combination buffer conductance, PH to 7.0 is adjusted, loading is cleaned with combination buffer, with 40ml elution buffer 20mM PB pH6.0 elutes destination protein, cleans pillar with the NaOH of 40ml, 10mM NaOH saves chromatographic column, washes to ferritin De- buffer carries out gel filtration detection and ion chromatography detection, which chromatographs to obtain the elution buffer of ferritin Middle destination protein purity is 94%, the rate of recovery 88.6%, carrying capacity 20mg/ml;
4) hydrophobic chromatography is handled: appropriate hydrophobic chromatoghaphy medium Phenyl Bestarose Fast Flow HS being taken to be packed into BXK16/20, column bed height are 10.5cm, chromatographic column are handled with 40ml 0.5M NaOH, with combination buffer 20mM PB 2M NaCl pH7.0 balances chromatographic column, takes the elution buffer sample 10ml of the ferritin obtained by step 3), sample adds NaCl It adjusts conductance extremely identical as the conductance of combination buffer, adjusts pH7.0, loading is cleaned with combination buffer, with elution buffer 20mM PB 1M NaCl pH7.0 elutes destination protein, cleans pillar, 10mM with 60ml NaOH after eluting impurity with 60ml pure water NaOH saves chromatographic column, carries out gel filtration detection to the elution buffer of ferritin and ion chromatography detects, the step is hydrophobic It is 98.47% that chromatography, which obtains destination protein purity in the elution buffer of ferritin, the rate of recovery 61%, and carrying capacity is 17.76mg/ml;
It is 27.89min that step 1), which can get filtrate sample gel filtration testing goal albumen appearance time refering to Fig. 5,;
Step 2) can get refering to Fig. 6 using anion chromatography medium DEAE Bestarose HighPerformance's Elution buffer sample gel filtration testing goal albumen appearance time is 27.86min;
Step 3) can get the elution buffer using cation chromatography media Diamond MMC mustang refering to Fig. 7 Sample gel filtration testing goal albumen appearance time is 27.91min;
Step 4) can get washing using hydrophobic chromatoghaphy medium Phenyl Bestarose Fast Flow HS refering to Fig. 8 De- buffer sample gel filtration testing goal albumen appearance time is 28.04min.
A kind of recombinant human iron separation and purification of protein method of the present invention, the present invention using anion chromatography, cation chromatography and Ferritin purity made from three step chromatography scheme of hydrophobic chromatography and the rate of recovery are high, and refering to Fig. 9 to 11, main peak becomes in ion detection figure Greatly, miscellaneous peak is smaller and smaller, purity >=97%, can reach medical supplies rank, does not need to carry out cumbersome desalination between every step chromatography Dilution operation, method is easy to operate, is suitble to large-scale production, by using gel filtration detection and ion chromatography detection to every step Chromatographic elution sample is detected, and the reliability of ferritin isolation and purification method is increased.
Above-described embodiment is the description of the invention, is not limitation of the invention, after any pair of simple transformation of the present invention Scheme all belong to the scope of protection of the present invention.

Claims (10)

1. a kind of recombinant human iron separation and purification of protein method, it is characterised in that: the following steps are included:
1) bacterium mud is obtained after the Escherichia coli bacteria liquid centrifugation after fermenting, and bacterium mud heated after being dissolved in buffer, is centrifuged or mistake Filter processing, obtains filtrate;
2) filtrate that step 1) obtains is separated using anion chromatography, collects the elution buffer of ferritin;
3) secondary separation is carried out using the elution buffer that cation chromatography obtains ferritin to step 2), collects ferritin Elution buffer;
4) it is separated three times using elution buffer of the hydrophobic chromatography to the ferritin that step 3) obtains, collects ferritin Elution buffer.
2. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: dissolve bacterium in the step 1) The buffer of mud is 5-100mM PB or Tris pH7.0, and the temperature range and time heated in the step 1) is respectively 70- 75 DEG C, 5-15min, filtration treatment uses 0.22um doughnut or membrane filtration processing mode in the step 1).
3. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: the step 2) specifically: The chromatographic column equipped with anion chromatography medium is taken, chromatographic column is handled with 0.5M NaOH, balances chromatographic column with combination buffer later Loading afterwards, then impurity is cleaned with cleaning buffer solution, it is eluted with elution buffer, collects the elution buffer of ferritin, The stronger impurity of binding ability is cleaned with 0.5M NaOH, saves chromatographic column with 10mM NaOH.
4. recombinant human iron separation and purification of protein method as claimed in claim 3, it is characterised in that: anion in the step 2) Chromatography media is Q Bestarose High Performance, Q Sepharose High Performance, DEAE Bestarose High Performance、DEAE Sepharose High Performance、SOURCE Q、Q Bestarose Fast Flow、Q Sepharose Fast Flow、DEAE Bestarose Fast Flow、DEAE Sepharose Fast Flow、Q Bestarose Big Beads、Q sepharose Big Beads、Q Bestarose Big Beads、Q sepharose Big Beads、Diamond Q、Capto Q、Diamond Q mustang、Capto Q One of mustang, Capto DEAE, Diamond DEAE or Diamond DEAE mustang;
Combination buffer is 5-100mM PB or Tris pH7.0 in the step 2);
Cleaning buffer solution is 5-100mM PB or MES pH6.0 or 5-100mM PB or Tris 0.1M NaCl in the step 2) One of pH7.0;
Elution buffer is 5-100mM NaAC pH4.5 or 5-100mMPB 0.25M NaCl pH7.0 in the step 2);
In the step 2) combination buffer balance chromatographic column to efflux PH and conductance with the PH of combination buffer and electricity It leads and is consistent.
5. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: the step 3) is specially; The chromatographic column equipped with cationic chromatography media is taken, chromatographic column is handled with 0.5M NaOH, balances chromatographic column with combination buffer later Loading afterwards, elution buffer are eluted, and the elution buffer of ferritin is collected, and clean binding ability ratio with 0.5M NaOH Stronger impurity saves chromatographic column with 10mM NaOH.
6. recombinant human iron separation and purification of protein method as claimed in claim 5, it is characterised in that: cationic in the step 3) Chromatography media is SP Bestarose High Performance, SP Sepharose High Performance, Diamond MMC、Capto MMC、Diamond MMC mustang、Capto MMC impres、SP Bestarose Fast Flow、SP Sepharose Fast Flow、Capto SP impres、Diamond SP mustang、CM Bestarose Fast Flow Or one of CM Sepharose Fast Flow;
Combination buffer is 5-100mM NaAc pH5.0 or 5-100mM NaAc 0.2M NaCl pH5.0 in the step 3);
Elution buffer is 5-100mM PB 0.01M NaCl pH6.0 or 5-100mM PB pH6.0 in the step 3);
In the step 3) combination buffer balance chromatographic column to efflux PH and conductance with the PH of combination buffer and electricity It leads and is consistent.
7. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: the step 4) is specific For;The chromatographic column equipped with hydrophobic chromatoghaphy medium is taken, chromatographic column is handled with 0.5M NaOH, is balanced chromatograph with combination buffer later Loading after column, then eluted with elution buffer, the elution buffer of ferritin is collected, impurity is eluted with pure water, uses 0.5M NaOH cleans chromatographic column, saves chromatographic column with 10mM NaOH.
8. recombinant human iron separation and purification of protein method as described in claim 7, it is characterised in that: hydrophobic in the step 4) Chromatography media be Butyl Bestarose High Performance, Butyl Sepharose High Performance, Diamond Butyl mustang、Capto Butyl impres、Butyl Bestarose Fast Flow、Phenyl Sepharose Fast Flow HS、Phenyl Sepharose Fast Flow LS、Phenyl Bestarose Fast Flow HS、Phenyl Bestarose Fast Flow LS、Butyl Sepharose Fast Flow、Diamond butyl、Capto butyl、Capto Phenyl HS、Capto Phenyl impres、Diamond Phenyl mustang Or one of Diamond Phenyl;
Combination buffer is 5-100mM PB or Tris 0.8-2M Na in the step 4)2SO4pH7.0,5-100mM PB or Tris 1.5-3M NaCl pH7.0,5-100mM PB or Tris 0.8-2.5M (NH4)2SO4PH7.0 or 5-100mM PB or Tris 0.8-2M K2One of HPO4pH7.0;
Elution buffer is 5-100mM PB or Tris 0.2-0.5M Na2SO4pH7.0,5-100mM PB in the step 4) Or Tris 0.8-1.2M NaCl pH7.0,5-100mM PB or Tris 0.4-0.8M (NH4)2SO4pH7.0、5-100mM PB Or Tris 0.4-0.8M K2One of HPO4pH7.0.
In the step 4) combination buffer balance chromatographic column to efflux PH and conductance with the PH of combination buffer and electricity It leads and is consistent.
9. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: the step 1), step 2), Step 3) and step 4) are both needed to carry out albumen Indexs measure.
10. recombinant human iron separation and purification of protein method as described in claim 1, it is characterised in that: the albumen index index Detection uses gel filtration detection and ion chromatography detection mode.
CN201811622011.8A 2018-12-28 2018-12-28 A kind of recombinant human iron separation and purification of protein method Pending CN109503704A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811622011.8A CN109503704A (en) 2018-12-28 2018-12-28 A kind of recombinant human iron separation and purification of protein method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811622011.8A CN109503704A (en) 2018-12-28 2018-12-28 A kind of recombinant human iron separation and purification of protein method

Publications (1)

Publication Number Publication Date
CN109503704A true CN109503704A (en) 2019-03-22

Family

ID=65756534

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811622011.8A Pending CN109503704A (en) 2018-12-28 2018-12-28 A kind of recombinant human iron separation and purification of protein method

Country Status (1)

Country Link
CN (1) CN109503704A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759986A (en) * 2019-10-18 2020-02-07 大连工业大学 Efficient preparation method of reversible self-assembled protein
CN111875696A (en) * 2020-08-17 2020-11-03 郑州伊美诺生物技术有限公司 Method for purifying Ferr
CN112646045A (en) * 2021-01-06 2021-04-13 海默斯(重庆)医学生物技术有限公司 Recombinant keratin separation and purification method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020092089A (en) * 2001-06-02 2002-12-11 한국생명공학연구원 Expression vector containing gene of human ferritin, transformant thereof and method for preparing human ferritin using the same
KR20040007892A (en) * 2002-07-11 2004-01-28 주식회사 바이오프로젠 Recombinant Human Ferritin Protein And A Process for Producing the Same
CN102127166A (en) * 2010-01-14 2011-07-20 中国科学院地质与地球物理研究所 Method for separating purified ferritins from biological tissues or engineering bacteria
CN107033237A (en) * 2017-05-11 2017-08-11 深圳市卫光生物制品股份有限公司 A kind of Human Plasma Apolipoprotein A I isolation and purification method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020092089A (en) * 2001-06-02 2002-12-11 한국생명공학연구원 Expression vector containing gene of human ferritin, transformant thereof and method for preparing human ferritin using the same
KR20040007892A (en) * 2002-07-11 2004-01-28 주식회사 바이오프로젠 Recombinant Human Ferritin Protein And A Process for Producing the Same
CN102127166A (en) * 2010-01-14 2011-07-20 中国科学院地质与地球物理研究所 Method for separating purified ferritins from biological tissues or engineering bacteria
CN107033237A (en) * 2017-05-11 2017-08-11 深圳市卫光生物制品股份有限公司 A kind of Human Plasma Apolipoprotein A I isolation and purification method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李志鹏等: "铁蛋白Ferritin原核表达和纯化及纳米颗粒胞外自组装", 《畜牧兽医学报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759986A (en) * 2019-10-18 2020-02-07 大连工业大学 Efficient preparation method of reversible self-assembled protein
CN110759986B (en) * 2019-10-18 2023-01-31 大连工业大学 Efficient preparation method of reversible self-assembled protein
CN111875696A (en) * 2020-08-17 2020-11-03 郑州伊美诺生物技术有限公司 Method for purifying Ferr
CN112646045A (en) * 2021-01-06 2021-04-13 海默斯(重庆)医学生物技术有限公司 Recombinant keratin separation and purification method

Similar Documents

Publication Publication Date Title
JP6743074B2 (en) Method for reducing the level of one or more impurities in a sample during protein purification
AU2014264697B2 (en) Continuous multistep process for purifying antibodies
CN109503704A (en) A kind of recombinant human iron separation and purification of protein method
KR101569783B1 (en) A Method of Antibody Purification
CN104672328B (en) A kind of production method of Human Antithrombin Ⅲ
CN102492040B (en) Method for purifying anti-HER2 or/and anti-HER3 antibody proteins
CN107383161A (en) The purifying of biomolecule
JP2017060488A (en) Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
CN112409477B (en) IgM purification method
CN103497248B (en) A kind of method of isolated and purified antibody from cells and supernatant
CN109929027B (en) Method for purifying recombinant fusion protein by linear elution step
CN105837687A (en) Anti-TNF-alpha monoclonal antibody chromatographic method
JP7430012B2 (en) Adalimumab NON-PROTEIN A purification method
CN107964044B (en) Method for purifying anti-CD 20 monoclonal antibody from milk sample
CN104710527B (en) A kind of endotoxin removal method of biological products
US20220267411A1 (en) Refining method of ophthalmic protein pharmaceutical
CN104109204A (en) Method for separating and purifying recombinant human lactoferrins from paddy rice seeds
CN114395015A (en) Recombinant granular protein product suitable for industrial production and preparation method thereof
EP4108674A1 (en) Optimized method for bevacizumab purification
CN107033236A (en) A kind of Mixed-Modechromatography method that human serum albumin is separated from yeast fermentation broth
CN114316066A (en) MNR2 protein purification method
CN109929038B (en) Purification method of VEGF (vascular endothelial growth factor) capture agent fusion protein
CN113480622A (en) Method for preparing and purifying recombinant pneumolysin
CN106519029A (en) Preparation process for A beta oligomer antibody
WO1995029187A1 (en) Chromatographic process for the copurification of chondroitinase i and ii proteins

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190322